Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$17,556,058
+$7,514,929 QoQ
Shares Held
14,637
+34.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#953
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 2%
None 98%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2025CallValue
$1,238,865
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Advisors Network LLC holds $55,348,452 across 12 Drug Manufacturers - General names. LLY ranks #1 (31.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,637 | $17,556,058 | |
| 2 | ABBV |
AbbVie Inc.
|
46,747 | $11,763,415 | |
| 3 | JNJ |
Johnson & Johnson
|
32,020 | $8,132,119 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,726 | $7,032,291 | |
| 5 | AMGN |
Amgen Inc
|
18,675 | $6,762,591 | |
| 6 | PFE |
Pfizer Inc
|
56,176 | $1,352,718 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,597 | $1,013,939 | |
| 8 | NVS |
Novartis AG
|
2,809 | $440,226 |
All Filings in LLY
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,556,058 | 14,637 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,041,129 | 10,917 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $14,676,906 | 13,657 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,343,228 | 13,556 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,167,272 | 11,760 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,238,865 | 1,500 | Call | Sole | 2025-04-15 | |
| 2025-03-31 | $9,066,014 | 10,977 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,158,000 | 1,500 | Call | Sole | 2025-02-25 | |
| 2024-12-31 | $8,890,352 | 11,516 | Shares | Sole | 2025-02-25 | |
| 2024-09-30 | $10,260,957 | 11,582 | Shares | Sole | 2024-10-25 | |
| 2024-09-30 | $1,328,910 | 1,500 | Call | Sole | 2024-10-25 | |
| 2024-06-30 | $905,380 | 1,000 | Call | Sole | 2024-08-09 | |
| 2024-06-30 | $10,194,578 | 11,260 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,860,964 | 11,390 | Shares | Sole | 2024-05-06 | |
| 2024-03-31 | $777,960 | 1,000 | Call | Sole | 2024-05-06 | |
| 2023-12-31 | $6,866,797 | 11,780 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $6,182,366 | 11,510 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $5,531,619 | 11,795 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,029,346 | 11,733 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,824,857 | 10,455 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,580,656 | 7,981 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,336,077 | 7,205 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,887,464 | 6,591 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,636,628 | 16,786 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,791,761 | 16,411 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,884,626 | 16,925 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,611,417 | 19,331 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,939,335 | 17,409 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,579,248 | 17,425 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,406,570 | 20,749 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,931,985 | 21,136 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||